CALY - calcyon neuron specific vesicular protein Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102130831
CALY Products (4)
| mRNA | Protein | Name |
|---|---|---|
| XM_045361783.1 | XP_045217718.1 | neuron-specific vesicular protein calcyon isoform X2 |
| XM_045361784.1 | XP_045217719.1 | neuron-specific vesicular protein calcyon isoform X2 |
| XM_045361780.1 | XP_045217715.1 | neuron-specific vesicular protein calcyon isoform X1 |
| XM_045361781.1 | XP_045217716.1 | neuron-specific vesicular protein calcyon isoform X1 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
neuron-specific vesicular protein calcyon |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(102)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0470 | Neomycin sulfate | Inhibitor | 99.86% | Unkown |
| HY-N0215 | L-Phenylalanine | Antagonist | 99.98% | Unkown |
| HY-10341 | Fasudil Hydrochloride | 99.97% | Yes | |
| HY-A0057 | Gabapentin | Inhibitor | 99.99% | Yes |
| HY-B0246 | Carbamazepine | 99.90% | Yes | |
| HY-B0782 | Acetazolamide | 99.85% | Yes | |
| HY-13764 | Tetrandrine | Inhibitor | 99.90% | Yes |
| HY-B0561 | Spironolactone | 99.81% | Yes | |
| HY-B0193A | Prazosin hydrochloride | 99.89% | Unkown | |
| HY-12542 | Dantrolene | Inhibitor | 99.93% | Yes |
| HY-75161 | (-)-Menthol | Activator | 99.79% | Unkown |
| HY-70037 | Cinacalcet | Agonist | 99.93% | Yes |
| HY-111964 | Lenacapavir | Inhibitor | 98.44% | Unkown |
| HY-B1193 | Terfenadine | 99.98% | Unkown | |
| HY-B1077 | Penfluridol | 99.93% | Unkown | |
| HY-B0632 | Diltiazem | Inhibitor | 99.70% | Yes |
| HY-B1221 | Flufenamic acid | 99.93% | Unkown | |
| HY-17404 | Cilnidipine | Inhibitor | 99.89% | Yes |
| HY-10341A | Fasudil | 99.98% | Yes | |
| HY-70037A | Cinacalcet hydrochloride | Agonist | 99.98% | Yes |
| HY-14603 | Clioquinol | 99.84% | Unkown | |
| HY-14656 | Diltiazem hydrochloride | Antagonist | 99.47% | Yes |
| HY-N1370 | Tanshinone IIA sulfonate sodium | Inhibitor | 99.77% | Unkown |
| HY-B0588 | Brinzolamide | Inhibitor | 99.91% | Unkown |
| HY-B0782A | Acetazolamide sodium | 99.54% | Yes | |
| HY-B1546A | Benzamil hydrochloride | Inhibitor | 99.70% | Unkown |
| HY-75839 | Dronedarone Hydrochloride | 99.99% | Unkown | |
| HY-15553A | Mibefradil dihydrochloride | Inhibitor | 99.71% | Yes |
| HY-12542A | Dantrolene sodium hemiheptahydrate | Inhibitor | 99.79% | Unkown |
| HY-A0057A | Gabapentin hydrochloride | Inhibitor | 98.0% | Yes |
| HY-B0109A | Dorzolamide hydrochloride | Inhibitor | 99.86% | Yes |
| HY-10932 | Aniracetam | Modulator | 99.94% | Unkown |
| HY-B1693 | Levomepromazine | 99.98% | Unkown | |
| HY-A0079 | Tetracaine | 99.87% | Unkown | |
| HY-B0358A | Flunarizine dihydrochloride | 99.90% | Yes | |
| HY-B0596 | Taltirelin | 99.91% | Unkown | |
| HY-14657 | Dantrolene sodium | Inhibitor | 99.79% | Yes |
| HY-B0358 | Flunarizine | 99.79% | Yes | |
| HY-B1424 | Benzthiazide | Inhibitor | 99.70% | Unkown |
| HY-B0684 | Iopamidol | 99.85% | Unkown | |
| HY-A0082 | Diphenidol hydrochloride | Antagonist | 99.06% | Unkown |
| HY-N0215R | L-Phenylalanine (Standard) | Antagonist | 99.99% | Unkown |
| HY-16952A | Bepridil hydrochloride hydrate | Antagonist | 99.86% | Unkown |
| HY-B1154 | Penbutolol sulfate | Antagonist | 98.89% | Unkown |
| HY-B0473 | Tetracaine hydrochloride | Inhibitor | 99.91% | Unkown |
| HY-B0021 | Doxifluridine | Inhibitor | 99.44% | Unkown |
| HY-B0246R | Carbamazepine (Standard) | 99.97% | Unkown | |
| HY-Y0258 | Benzocaine | 99.98% | Unkown | |
| HY-B0551 | Doxapram | Inhibitor | 99.70% | Unkown |
| HY-Z0478 | (-)-Limonene | Inhibitor | 99.42% | Unkown |
| HY-103370 | Talniflumate | Inhibitor | 99.90% | Yes |
| HY-B0380 | Trimebutine | 99.42% | Yes | |
| HY-107929 | Calcium polystyrene sulfonate | / | Unkown | |
| HY-B0380A | Trimebutine maleate | 99.66% | Yes | |
| HY-Y0258A | Benzocaine (hydrochloride) | Modulator | 99.83% | Unkown |
| HY-B0549A | Flavoxate hydrochloride | 99.70% | Yes | |
| HY-W042301 | Xipamide | 99.74% | Unkown | |
| HY-107319 | Almitrine mesylate | Inhibitor | 98.88% | Unkown |
| HY-B0551A | Doxapram hydrochloride hydrate | Inhibitor | 99.28% | Unkown |
| HY-109056 | Elsulfavirine | Inhibitor | 99.90% | Unkown |
| HY-121235 | Clonixin | Inhibitor | 98.88% | Unkown |
| HY-U00212 | Aranidipine | Antagonist | 99.12% | Unkown |
| HY-121186 | Bevantolol hydrochloride | Antagonist | 98.98% | Yes |
| HY-17613 | Evocalcet | Activator | 99.28% | Unkown |
| HY-109545 | Isopropyl unoprostone | Activator | 98.42% | Unkown |
| HY-16216 | Gabapentin enacarbil | Inhibitor | 99.90% | Yes |
| HY-111964A | Lenacapavir sodium | Inhibitor | 99.86% | Unkown |
| HY-112961 | Patiromer | Inhibitor | 95.0% | Unkown |
| HY-128370 | Calcium trinatrium diethylenetriaminepentaacetic acid hydrate | Inhibitor | 98.0% | Unkown |
| HY-A0135 | Enflurane | Inhibitor | 98.0% | Unkown |
| HY-A0236 | Aprindine | Inhibitor | 98.43% | Unkown |
| HY-B0562 | Methyclothiazide | 99.49% | Unkown | |
| HY-B0596A | Taltirelin acetate | 99.75% | Unkown | |
| HY-P1769 | Angiotensin II (5-8), human | 99.74% | Unkown | |
| HY-109106A | Upacicalcet sodium | Agonist | 99.91% | Unkown |
| HY-B0549 | Flavoxate | 98.07% | Yes | |
| HY-10341C | Fasudil dihydrochloride | 99.98% | Yes | |
| HY-116790 | (-)-Penbutolol | Antagonist | 99.74% | Unkown |
| HY-B1471 | Fluorometholone acetate | Inhibitor | 98.54% | Unkown |
| HY-15553 | Mibefradil | Inhibitor | / | Unkown |
| HY-B0109 | Dorzolamide | Inhibitor | / | Unkown |
| HY-109106 | Upacicalcet | Agonist | / | Unkown |
| HY-150520 | Neomycin | Inhibitor | / | Unkown |
| HY-10341B | Fasudil hydrochloride semihydrate | / | Unkown | |
| HY-106916 | Unoprostone | Activator | 99.0% | Unkown |
| HY-121166 | Levobetaxolol | Antagonist | / | Unkown |
| HY-14656R | Diltiazem hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-75839R | Dronedarone Hydrochloride (Standard) | / | Unkown | |
| HY-A0270 | Diphenidol | Antagonist | / | Unkown |
| HY-B0021R | Doxifluridine (Standard) | Inhibitor | / | Unkown |
| HY-B0109AR | Dorzolamide hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0193AR | Prazosin hydrochloride (Standard) | / | Unkown | |
| HY-B0401A | Tolbutamide sodium | Inducer | / | Unkown |
| HY-B0588A | Brinzolamide hydrochloride | Inhibitor | / | Unkown |
| HY-B0588R | Brinzolamide (Standard) | Inhibitor | / | Unkown |
| HY-B1546 | Benzamil | Inhibitor | / | Unkown |
| HY-B1558 | Bifemelane | / | Unkown | |
| HY-P1792 | Angiotensin II (1-4), human | Agonist | / | Unkown |
| HY-P1792A | Angiotensin II (1-4), human TFA | Agonist | / | Unkown |
| HY-121235R | Clonixin (Standard) | Inhibitor | / | Unkown |
| HY-B1693R | Levomepromazine (Standard) | / | Unkown | |
| HY-Y0258AR | Benzocaine (hydrochloride) (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(74)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N6687 | Calcimycin | 99.12% | Phase 4 | |
| HY-100560 | Abscisic acid | 99.78% | Phase 4 | |
| HY-N6687A | Calcimycin hemicalcium salt | / | Phase 4 | |
| HY-N6687B | Calcimycin hemimagnesium | / | Phase 4 | |
| HY-13898 | Taselisib | Inhibitor | 99.75% | Phase 3 |
| HY-50694 | Senicapoc | Inhibitor | 99.91% | Phase 3 |
| HY-10805 | Almorexant | 99.96% | Phase 3 | |
| HY-15724 | Vercirnon | Antagonist | 98.01% | Phase 3 |
| HY-17449 | Fosbretabulin disodium | 99.91% | Phase 3 | |
| HY-10805A | Almorexant hydrochloride | 99.98% | Phase 3 | |
| HY-106449 | Recoflavone | 98.0% | Phase 3 | |
| HY-14797 | Ombrabulin | Inhibitor | 98.53% | Phase 3 |
| HY-18256 | Ombrabulin hydrochloride | Inhibitor | 99.57% | Phase 3 |
| HY-121872 | DP-b99 | Inhibitor | 95.0% | Phase 3 |
| HY-145567 | Fasedienol | 99.68% | Phase 3 | |
| HY-Z7721 | (Rac)-Beraprost sodium | Inhibitor | 99.0% | Phase 3 |
| HY-113970 | Nebracetam | / | Phase 3 | |
| HY-15855 | Fosbretabulin tromethamine | Modulator | / | Phase 3 |
| HY-P5796 | FS-2 | Inhibitor | / | Phase 3 |
| HY-118962 | E913 | / | Phase 3 | |
| HY-50876 | Daporinad | 99.91% | Phase 2 | |
| HY-N1584 | Halofuginone | 99.28% | Phase 2 | |
| HY-13513 | U-104 | Inhibitor | 99.95% | Phase 2 |
| HY-10007 | NPS-2143 | Antagonist | 99.94% | Phase 2 |
| HY-101064 | Fmoc-leucine | 99.91% | Phase 2 | |
| HY-N1584A | Halofuginone hydrobromide | 99.85% | Phase 2 | |
| HY-115864 | Osavampator | Activator | 99.74% | Phase 2 |
| HY-10167A | Tecalcet Hydrochloride | Modulator | 99.43% | Phase 2 |
| HY-15293B | JTV-519 hemifumarate | Inhibitor | 99.74% | Phase 2 |
| HY-10066 | Nelivaptan | Antagonist | 99.89% | Phase 2 |
| HY-118467 | Benzolamide | Inhibitor | 99.59% | Phase 2 |
| HY-100414 | Soraprazan | Inhibitor | 99.78% | Phase 2 |
| HY-15724A | Vercirnon sodium | Antagonist | 98.04% | Phase 2 |
| HY-B0340 | Nefiracetam | Activator | 99.87% | Phase 2 |
| HY-119850 | Aladorian | Modulator | 99.55% | Phase 2 |
| HY-147301 | Resomelagon | Agonist | 98.79% | Phase 2 |
| HY-N0842 | Bevirimat | Inhibitor | 99.82% | Phase 2 |
| HY-19721 | ABT-639 | Inhibitor | 99.32% | Phase 2 |
| HY-100779 | Rimacalib | Inhibitor | 99.14% | Phase 2 |
| HY-147301A | Resomelagon acetate | Agonist | 99.15% | Phase 2 |
| HY-100298 | Caldaret | Inhibitor | 98.35% | Phase 2 |
| HY-100934 | SC-9 | Activator | 99.33% | Phase 2 |
| HY-137459 | Vocacapsaicin | Agonist | / | Phase 2 |
| HY-137459A | Vocacapsaicin hydrochloride | Antagonist | 95.66% | Phase 2 |
| HY-15293A | JTV-519 free base | Inhibitor | / | Phase 2 |
| HY-135317B | Emavusertib hydrochloride | / | Phase 2 | |
| HY-10049 | CP 122721 | Antagonist | / | Phase 2 |
| HY-105269A | Org 30029 hydrochloride | Activator | / | Phase 2 |
| HY-106904 | Nexopamil | Antagonist | / | Phase 2 |
| HY-110312 | JTV-519 fumarate | / | Phase 2 | |
| HY-113037B | Farnesyl pyrophosphate | Agonist | / | Phase 2 |
| HY-121535 | Levosemotiadil | Inhibitor | / | Phase 2 |
| HY-169115 | PD-0299685 | / | Phase 2 | |
| HY-19397 | BMS-223131 | / | Phase 2 | |
| HY-101616 | ABT-639 hydrochloride | Inhibitor | / | Phase 2 |
| HY-106415 | Terflavoxate | Antagonist | / | Phase 2 |
| HY-106927 | Bay Y5959 | Agonist | / | Phase 2 |
| HY-114826S | Prostaglandin E2-1-glyceryl ester-d5 | Activator | / | Phase 2 |
| HY-108496 | Sphingosine-1-phosphate | Agonist | 99.69% | Phase 1 |
| HY-101093 | CA-170 | Inhibitor | 99.39% | Phase 1 |
| HY-16935 | Mavatrep | Antagonist | 99.67% | Phase 1 |
| HY-100886 | BAY1082439 | 99.35% | Phase 1 | |
| HY-107111 | GSK1034702 | Agonist | 99.78% | Phase 1 |
| HY-NP009 | α-Lactalbumin | Inhibitor | 99.9% | Phase 1 |
| HY-126077 | MTI-31 | Inhibitor | 99.98% | Phase 1 |
| HY-129851 | NTP42 | Antagonist | 98.58% | Phase 1 |
| HY-137849 | RK-582 | Inhibitor | 98.05% | Phase 1 |
| HY-120588 | BI 639667 | Antagonist | 98.87% | Phase 1 |
| HY-115681 | (2R/S)-6-PNG | Inhibitor | 99.96% | Phase 1 |
| HY-133011 | nAChR agonist 1 | Agonist | 98.35% | Phase 1 |
| HY-107111A | GSK1034702 hydrochloride | Agonist | / | Phase 1 |
| HY-114793 | AL-12180 | Agonist | / | Phase 1 |
| HY-118148 | UK-66914 | Inhibitor | / | Phase 1 |
| HY-121701 | SR33805 analog | Antagonist | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99409 | Oregovomab | 99.66% | Phase 3 | |
| HY-P991646 | ING-1 | 99.0% | Phase 1 | |
| HY-P991887 | CA9hu-1 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(1055)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-18723 | Yoda 1 | 99.97% | Unkown | |
| HY-13434 | Ionomycin | 99.27% | Unkown | |
| HY-13433 | Thapsigargin | 99.95% | Unkown | |
| HY-100545 | BAPTA-AM | Inhibitor | 99.68% | Unkown |
| HY-112879 | Mito-TEMPO | 99.19% | Unkown | |
| HY-101896 | Fluo-4 AM | 99.84% | Unkown | |
| HY-W009724 | 2-Aminoethyl diphenylborinate | 98.86% | Unkown | |
| HY-D0989 | Rhod-2 AM | ≥97.0% | Unkown | |
| HY-D0861 | EGTA | 99.89% | Unkown | |
| HY-100202 | TPEN | 99.91% | Unkown | |
| HY-N0219 | Bicuculline | Antagonist | 99.98% | Unkown |
| HY-13434A | Ionomycin calcium | 98.32% | Unkown | |
| HY-19608 | GSK1016790A | 99.93% | Unkown | |
| HY-100350 | CA-074 methyl ester | Inhibitor | 99.81% | Unkown |
| HY-100168 | BAPTA | Inhibitor | 98.10% | Unkown |
| HY-15084B | Dizocilpine | Antagonist | 99.95% | Unkown |
| HY-103350 | CA-074 | Inhibitor | 99.94% | Unkown |
| HY-126010 | Dooku1 | Antagonist | 99.93% | Unkown |
| HY-10588 | Bay K 8644 | Agonist | 99.96% | Unkown |
| HY-19805 | STO-609 | Inhibitor | 98.20% | Unkown |
| HY-100831 | YM-58483 | Inhibitor | 99.38% | Unkown |
| HY-12323 | ISX-9 | Activator | 99.76% | Unkown |
| HY-P0221 | PACAP (1-38), human, ovine, rat | Inducer | 99.99% | Unkown |
| HY-D1024 | Coelenterazine h | 99.41% | Unkown | |
| HY-138620 | MCU-i4 | Inhibitor | 99.87% | Unkown |
| HY-101455 | CDN1163 | Activator | 99.90% | Unkown |
| HY-119287 | TSQ | 99.50% | Unkown | |
| HY-100912 | W-7 hydrochloride | 99.96% | Unkown | |
| HY-118630 | Vacuolin-1 | Inhibitor | 98.54% | Unkown |
| HY-101379A | 8-Bromo-cGMP sodium | Inhibitor | 99.89% | Unkown |
| HY-103312 | Xestospongin C | Inhibitor | 99.9% | Unkown |
| HY-P1410B | D-GsMTx4 | Inhibitor | 99.44% | Unkown |
| HY-123071 | Box5 | Antagonist | 98.81% | Unkown |
| HY-134923 | CA77.1 | Inducer | 99.92% | Unkown |
| HY-Y0669 | Pipecolic acid | Inhibitor | 99.92% | Unkown |
| HY-153306 | Zovegalisib | Inhibitor | 98.80% | Unkown |
| HY-100973A | Adenosine 5′-diphosphoribose sodium | 99.47% | Unkown | |
| HY-15754 | CGP37157 | Inhibitor | 99.87% | Unkown |
| HY-D1498 | Mag-Fluo-4 AM | 96.0% | Unkown | |
| HY-D0973 | EGTA-AM | 99.77% | Unkown | |
| HY-W019981B | Magnesium chloride hexahydrate, for molecular biology | Activator | 99.40% | Unkown |
| HY-103319 | Calmidazolium chloride | Antagonist | 99.94% | Unkown |
| HY-100973 | Adenosine 5′-diphosphoribose | 98.21% | Unkown | |
| HY-N6732 | K-252a | Inhibitor | 99.45% | Unkown |
| HY-P5912 | GluN1(356-385) | Inhibitor | 99.95% | Unkown |
| HY-101897 | Fura-2 AM | ≥99.0% | Unkown | |
| HY-P0256 | Apamin | Inhibitor | 99.96% | Unkown |
| HY-N0215S12 | L-Phenylalanine-d5 | Antagonist | 99.90% | Unkown |
| HY-50722 | NNC 55-0396 | Inhibitor | 98.43% | Unkown |
| HY-15515 | SEA0400 | Inhibitor | 99.95% | Unkown |
| HY-D0716 | Fluo-3AM | ≥99.0% | Unkown | |
| HY-120691A | GSK205 | Antagonist | 99.47% | Unkown |
| HY-103474 | Bicuculline methiodide | Inhibitor | 99.93% | Unkown |
| HY-101044 | PPADS tetrasodium | 99.9% | Unkown | |
| HY-107859 | Tris(2-chloroethyl) phosphate | 97.07% | Unkown | |
| HY-113037C | Farnesyl pyrophosphate ammonium | Agonist | 95.39% | Unkown |
| HY-P0033 | Argireline | Inhibitor | 99.86% | Unkown |
| HY-N1502 | Carboxyatractyloside tripotassium | 99.97% | Unkown | |
| HY-15124 | (S)-(-)-Bay-K-8644 | Agonist | 99.22% | Unkown |
| HY-108465 | Pyr3 | Inhibitor | 99.83% | Unkown |
| HY-P10798A | Eloralintide sodium | Inhibitor | 99.72% | Unkown |
| HY-131614 | TPC2-A1-N | Inhibitor | 99.86% | Unkown |
| HY-107543 | 8-pCPT-2′-O-Me-cAMP sodium | Activator | 99.81% | Unkown |
| HY-116330A | Hyperforin dicyclohexylammonium salt | 99.48% | Unkown | |
| HY-W019981C | Magnesium chloride hexahydrate, for cell culture | Activator | / | Unkown |
| HY-N6778 | Paxilline | Inhibitor | 99.91% | Unkown |
| HY-P1410C | D-GsMTx4 TFA | Inhibitor | 99.89% | Unkown |
| HY-P3419 | PAMP-12 (unmodified) | 99.40% | Unkown | |
| HY-116522 | AR420626 | 98.40% | Unkown | |
| HY-108599 | DCP-LA | 98.0% | Unkown | |
| HY-I0096 | Indole-2-carboxylic acid | 99.86% | Unkown | |
| HY-W127512 | 5β-Cholanic acid | 99.87% | Unkown | |
| HY-113328 | Aminoadipic acid | 99.94% | Unkown | |
| HY-103192 | MDL12330A | Inhibitor | 99.82% | Unkown |
| HY-N6789 | KT5720 | Inhibitor | ≥99.0% | Unkown |
| HY-101906 | DC260126 | 99.57% | Unkown | |
| HY-135897 | Urolithin C | 98.00% | Unkown | |
| HY-107411 | Bromoenol lactone | Inhibitor | 99.59% | Unkown |
| HY-N0043 | Ginsenoside Rd | Inhibitor | 99.88% | Unkown |
| HY-110105 | NS8593 hydrochloride | Inhibitor | 99.76% | Unkown |
| HY-33299 | Serpin B9-IN-1 | 97.42% | Unkown | |
| HY-16697 | CID 16020046 | Antagonist | 99.81% | Unkown |
| HY-125944 | MitoTEMPO hydrate | 98.03% | Unkown | |
| HY-133168 | Englerin A | Activator | 99.50% | Unkown |
| HY-N0215S8 | L-Phenylalanine-13C6 | Antagonist | 99.87% | Unkown |
| HY-15416 | NS309 | Activator | 99.09% | Unkown |
| HY-12949 | ML204 | Inhibitor | 98.45% | Unkown |
| HY-116429 | Maresin 1 | Inhibitor | 99.03% | Unkown |
| HY-P5712 | Gramicidin S | Inhibitor | 99.89% | Unkown |
| HY-B2149 | Quadrol | Activator | 99.96% | Unkown |
| HY-103660 | 18:0 LYSO-PE | 99.0% | Unkown | |
| HY-P6292A | KS-133 TFA | Antagonist | 98.95% | Unkown |
| HY-101017 | Palmitoylcarnitine chloride | 98.0% | Unkown | |
| HY-N2522 | Carboxyatractyloside dipotassium | 99.57% | Unkown | |
| HY-W194810 | MCU-i11 | 98.05% | Unkown | |
| HY-111208 | CCT129957 | Inhibitor | 99.16% | Unkown |
| HY-13103 | NS 11021 | Activator | 99.51% | Unkown |
| HY-149662 | TMDJ-035 | Inhibitor | 99.92% | Unkown |
| HY-162501 | Yaddle1 | Agonist | 99.98% | Unkown |
| HY-Y0413 | Biacetyl monoxime | Inhibitor | 98.0% | Unkown |
| HY-W048457 | Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) | Control | ≥97.0% | Unkown |
| HY-114252 | Strophanthidin | Inhibitor | 98.71% | Unkown |
| HY-131648 | 1-Oleoyl-2-acetyl-sn-glycerol | Activator | 99.90% | Unkown |
| HY-P0190 | Iberiotoxin | Inhibitor | 99.71% | Unkown |
| HY-15415 | KB-R7943 mesylate | Inhibitor | 99.16% | Unkown |
| HY-123071A | Box5 TFA | Antagonist | 99.50% | Unkown |
| HY-Y1667 | 2,6-Dibromophenol | Inhibitor | 99.76% | Unkown |
| HY-14229 | TGR5 Receptor Agonist | Agonist | 99.67% | Unkown |
| HY-100168B | BAPTA tetrapotassium | Inhibitor | 99.42% | Unkown |
| HY-103306 | Ryanodine | 99.91% | Unkown | |
| HY-120261 | GB-88 | Inhibitor | 98.66% | Unkown |
| HY-121119 | MRS 1523 | 99.97% | Unkown | |
| HY-P1080A | ω-Agatoxin IVA TFA | Inhibitor | 99.52% | Unkown |
| HY-N0515 | Ophiopogonin D | 99.80% | Unkown | |
| HY-107582 | JW480 | Inhibitor | 99.82% | Unkown |
| HY-N0601 | Ginsenoside Rf | Inhibitor | 99.48% | Unkown |
| HY-P1345A | TLQP-21 TFA | Agonist | 99.90% | Unkown |
| HY-119401 | CAY10444 | Antagonist | 98.0% | Unkown |
| HY-162426 | UNC-CA2-103 | Inhibitor | 99.26% | Unkown |
| HY-P3278 | Caloxin 2A1 | Inhibitor | 99.97% | Unkown |
| HY-100168A | BAPTA tetrasodium | Inhibitor | 99.70% | Unkown |
| HY-103307 | FPL64176 | Agonist | 99.86% | Unkown |
| HY-107658 | SN 6 | Inhibitor | 99.79% | Unkown |
| HY-N0607 | Ginsenoside Ro | 99.81% | Unkown | |
| HY-D0861A | EGTA tetrasodium | 99.93% | Unkown | |
| HY-157562 | DS68591889 | 99.18% | Unkown | |
| HY-12496 | NS-1619 | 98.06% | Unkown | |
| HY-15292 | S107 | Ligand | 99.77% | Unkown |
| HY-D1903 | Fura Red AM | 91.00% | Unkown | |
| HY-P2847 | Urocortin II, mouse | Agonist | 99.94% | Unkown |
| HY-N15721 | Tryptophan-cholic acid | 99.75% | Unkown | |
| HY-137790 | Bicuculline methochloride | Antagonist | 99.80% | Unkown |
| HY-16690 | BTS | Inhibitor | 99.79% | Unkown |
| HY-B0006C | (R)-Carvedilol | Inhibitor | 98.78% | Unkown |
| HY-W017387 | Sodium α-ketoisocaproate | 98.0% | Unkown | |
| HY-136409 | N-Decanoyl-L-homoserine lactone | 98.40% | Unkown | |
| HY-120072 | PF-3450074 | Inhibitor | 98.89% | Unkown |
| HY-10171 | NPS-2143 hydrochloride | Antagonist | 99.98% | Unkown |
| HY-126750 | GNF362 | Inhibitor | 99.86% | Unkown |
| HY-106844A | (+)-EMD 57033 | 99.72% | Unkown | |
| HY-N0663 | Talatisamine | 99.77% | Unkown | |
| HY-W011235 | Norfluoxetine hydrochloride | 99.58% | Unkown | |
| HY-16689 | VU 0240551 | Inhibitor | 99.70% | Unkown |
| HY-D1422 | ER Tracker Yellow | 96.91% | Unkown | |
| HY-N2344 | Procyanidin A1 | Inhibitor | 99.96% | Unkown |
| HY-19408 | Pyr10 | Inhibitor | 99.95% | Unkown |
| HY-103309 | ML218 | Inhibitor | 99.49% | Unkown |
| HY-112698 | CA-5f | 99.14% | Unkown | |
| HY-19749 | PD 151746 | Inhibitor | 95.03% | Unkown |
| HY-N0215S1 | L-Phenylalanine-d8 | Antagonist | 99.99% | Unkown |
| HY-NP164 | Concanavalin A-HRP | / | Unkown | |
| HY-P3278A | Caloxin 2A1 TFA | Inhibitor | 99.92% | Unkown |
| HY-160023 | Elisrasib | 98.50% | Unkown | |
| HY-101366 | A-61603 | Agonist | 99.34% | Unkown |
| HY-124416 | ML604086 | Inhibitor | 99.78% | Unkown |
| HY-160099 | 20-5,14-HEDE | 98.34% | Unkown | |
| HY-B0782R | Acetazolamide (Standard) | 99.57% | Unkown | |
| HY-N2500 | Deoxypodophyllotoxin | 99.86% | Unkown | |
| HY-P1821 | Myelin Basic Protein | 99.55% | Unkown | |
| HY-120026 | KB130015 | 98.45% | Unkown | |
| HY-16992A | W-54011 | 99.57% | Unkown | |
| HY-120597 | SAK3 | Activator | 99.80% | Unkown |
| HY-15671 | GKA50 | Activator | 99.84% | Unkown |
| HY-DY1020 | Rhod-2 AM (solution) | / | Unkown | |
| HY-N0126 | Xanthone | Inhibitor | 99.97% | Unkown |
| HY-12759 | CARM1-IN-1 | Inhibitor | 95.0% | Unkown |
| HY-120528A | GB-110 hydrochloride | Agonist | 99.86% | Unkown |
| HY-110243 | CAIX Inhibitor S4 | Inhibitor | 99.04% | Unkown |
| HY-130311 | 2-Linoleoyl glycerol | Inhibitor | 99.9% | Unkown |
| HY-103320A | Calhex 231 hydrochloride | Inhibitor | 99.81% | Unkown |
| HY-101015A | OBAA | 99.31% | Unkown | |
| HY-18071 | BI-9627 | Inhibitor | 99.71% | Unkown |
| HY-N0724 | Mesaconitine | Activator | 99.19% | Unkown |
| HY-N7690 | 3,5,7,3′,4′-Pentamethoxyflavone | Inhibitor | 99.69% | Unkown |
| HY-N0215S10 | L-Phenylalanine-13C9 | Antagonist | 98.09% | Unkown |
| HY-P0190A | Iberiotoxin TFA | Inhibitor | 99.43% | Unkown |
| HY-W001538 | S-Propargylcysteine | 97.0% | Unkown | |
| HY-157453 | CCR4 antagonist 4 | Antagonist | 98.92% | Unkown |
| HY-N7848 | Linoleamide | Inhibitor | 99.4% | Unkown |
| HY-101360 | 1-EBIO | Agonist | 99.96% | Unkown |
| HY-N0910 | Notoginsenoside Ft1 | 99.49% | Unkown | |
| HY-100712 | DPO-1 | Inhibitor | 98.39% | Unkown |
| HY-115719 | NR162 | Inhibitor | 99.7% | Unkown |
| HY-14350 | AC-55541 | Agonist | 99.40% | Unkown |
| HY-N0252 | Catharanthine | Inhibitor | 99.46% | Unkown |
| HY-P1366 | des-Gln14-Ghrelin | 98.21% | Unkown | |
| HY-101329 | Anthracene-9-carboxylic acid | Inhibitor | 99.21% | Unkown |
| HY-103316A | Ned 19 | Inhibitor | 99.92% | Unkown |
| HY-136460 | Calcium ionophore I | 99.6% | Unkown | |
| HY-162774A | GRP75-IN-1 dihydrochloride | Inducer | 99.75% | Unkown |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-N2081 | Skimmianine | Inhibitor | 99.90% | Unkown |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-N8307 | Syringaresinol | 99.66% | Unkown | |
| HY-P10655 | Caloxin 1C2 | Inhibitor | 99.47% | Unkown |
| HY-W131725 | (+)-Norfenfluramine | Agonist | 98.79% | Unkown |
| HY-32933 | 4-Acetylphenylboronic acid | Inhibitor | 99.96% | Unkown |
| HY-16639 | ML314 | Agonist | 99.52% | Unkown |
| HY-101087 | Benzenesulphonamide | Inhibitor | 99.75% | Unkown |
| HY-118010A | (+)-Norfenfluramine hydrochloride | Agonist | 99.77% | Unkown |
| HY-34740 | Ethylmalonic acid | Inhibitor | 98.0% | Unkown |
| HY-101955A | (2R,6R)-Hydroxynorketamine hydrochloride | 99.91% | Unkown | |
| HY-114400 | TRPV4 agonist-1 free base | Agonist | 99.69% | Unkown |
| HY-130118 | MRGPRX1 agonist 1 | Agonist | 99.95% | Unkown |
| HY-108593 | BMS-191011 | Activator | 99.56% | Unkown |
| HY-131900 | Protein kinase inhibitor H-7 | Inhibitor | 99.96% | Unkown |
| HY-158779 | Sulfane sulfur probe 4 | 97.3% | Unkown | |
| HY-D1024A | Coelenterazine h hydrochloride | 99.65% | Unkown | |
| HY-N0084 | Betulinaldehyde | Inhibitor | 98.72% | Unkown |
| HY-N0642 | α-L-Rhamnose monohydrate | Activator | 98.0% | Unkown |
| HY-N4104 | Agaric acid | 99.45% | Unkown | |
| HY-N7063 | Nerol | 98.97% | Unkown | |
| HY-P1075 | CALP3 | Inhibitor | 99.55% | Unkown |
| HY-P1341 | OXA(17-33) | 97.48% | Unkown | |
| HY-W041308 | DCOIT | Agonist | 99.87% | Unkown |
| HY-W110910 | Eriochrome black T, Indicator | / | Unkown | |
| HY-12498 | GV-58 | Agonist | 99.22% | Unkown |
| HY-108608 | o-3M3FBS | 99.79% | Unkown | |
| HY-116291 | 4α-Phorbol 12,13-didecanoate | 99.30% | Unkown | |
| HY-124873 | SERCA2a activator 1 | Activator | 99.71% | Unkown |
| HY-128747A | α-D-Glucose-1-phosphate disodium hydrate | 98.0% | Unkown | |
| HY-129126 | NC9 | Inhibitor | 99.98% | Unkown |
| HY-12927 | SX-517 | Antagonist | 99.90% | Unkown |
| HY-34740S | Ethylmalonic acid-d3 | Inhibitor | 98.0% | Unkown |
| HY-N0215S11 | L-Phenylalanine-13C9,15N | Antagonist | 99.42% | Unkown |
| HY-N0215S5 | L-Phenylalanine-15N | Antagonist | 98.38% | Unkown |
| HY-Y1422I | Lipase,Pseudomonas fluorescens (Immobilized) | / | Unkown | |
| HY-101396 | ICA-069673 | Activator | 99.20% | Unkown |
| HY-100783 | (-)-Bicuculline methobromide | Antagonist | 99.94% | Unkown |
| HY-104058 | BAPTA Green 1AM | 92.0% | Unkown | |
| HY-P3089A | Dendrotoxin K TFA | Inhibitor | 99.84% | Unkown |
| HY-P3965 | 16-38-Thymosin β4 (cattle) | Activator | 98.05% | Unkown |
| HY-W010710 | IPrAuCl | Inhibitor | 98.2% | Unkown |
| HY-12949A | ML204 hydrochloride | Inhibitor | 99.74% | Unkown |
| HY-103442 | CGP52411 | Inhibitor | 99.82% | Unkown |
| HY-108464A | Phenamil methanesulfonate | Inhibitor | 98.1% | Unkown |
| HY-110018 | N-Arachidonyldopamine | 98.36% | Unkown | |
| HY-117073 | ITH12575 | Inhibitor | 98.84% | Unkown |
| HY-135556 | Norfluoxetine | 98.71% | Unkown | |
| HY-136661 | (-)-N6-Phenylisopropyl adenosine | Agonist | 99.45% | Unkown |
| HY-175416 | Yoda2 | Agonist | 99.57% | Unkown |
| HY-D0202 | Arsenazo III | 95.0% | Unkown | |
| HY-DY1028 | Fluo-4 AM (solution) | / | Unkown | |
| HY-E70200 | Recombinant Kex2 protease | / | Unkown | |
| HY-N2060 | Evocarpine | 99.88% | Unkown | |
| HY-P1077A | CALP1 TFA | 98.15% | Unkown | |
| HY-P1821A | Myelin basic protein (4-14) TFA | 99.41% | Unkown | |
| HY-W012399 | 2,5-Di-tert-butylhydroquinone | 99.73% | Unkown | |
| HY-W074975 | CL 5343 | Inhibitor | 99.91% | Unkown |
| HY-W181102 | NFAT Inhibitor-2 | Inhibitor | 98.42% | Unkown |
| HY-12759A | CARM1-IN-1 hydrochloride | Inhibitor | 95.17% | Unkown |
| HY-137175 | TMBIM6 antagonist-1 | Antagonist | 98.92% | Unkown |
| HY-137458 | Vevorisertib | Inhibitor | 98.03% | Unkown |
| HY-103317 | NAADP | 95.8% | Unkown | |
| HY-108496S | Sphingosine-1-phosphate-d7 | Agonist | 99.9% | Unkown |
| HY-108607 | PACOCF3 | Inhibitor | 98.0% | Unkown |
| HY-135746 | OR-1896 | 99.04% | Unkown | |
| HY-135891 | AZD2423 | Antagonist | 99.91% | Unkown |
| HY-B1671 | (+)-Kavain | 99.98% | Unkown | |
| HY-D0110A | Fura-2 pentapotassium | 97.0% | Unkown | |
| HY-N0215S3 | L-Phenylalanine-d2 | Antagonist | 99.00% | Unkown |
| HY-N0215S7 | L-Phenylalanine-3-13C | Antagonist | 99.56% | Unkown |
| HY-N1584C | Halofuginone lactate | 98.32% | Yes | |
| HY-N6688 | Verruculogen | Inhibitor | 98.08% | Unkown |
| HY-N7575 | Lacto-N-fucopentaose II | 98.0% | Unkown | |
| HY-P1831 | Proadrenomedullin (1-20), human | 99.53% | Unkown | |
| HY-P5189A | His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA | 99.94% | Unkown | |
| HY-W749867 | Ca(II)-EDTA disodium dihydrate | 99.9% | Unkown | |
| HY-N0215S2 | L-Phenylalanine-13C | Antagonist | 99.66% | Unkown |
| HY-N7491A | Ent-(+)-Verticilide | Inhibitor | 99.91% | Unkown |
| HY-100656 | Desmethyl cariprazine | Antagonist | 98.08% | Unkown |
| HY-110023 | Zimelidine dihydrochloride | Inhibitor | 98.08% | Unkown |
| HY-110153 | NS19504 | Activator | 99.93% | Unkown |
| HY-113037CS | Farnesyl pyrophosphate-d2 triammonium | Agonist | 95.78% | Unkown |
| HY-128678 | ORM-10103 | Inhibitor | 99.43% | Unkown |
| HY-136909 | SR33805 | Antagonist | 99.78% | Unkown |
| HY-145127 | ETZ | 99.84% | Unkown | |
| HY-146268 | CaMKIIα-IN-1 | Inhibitor | 98.53% | Unkown |
| HY-161104 | Kv2.1-IN-1 | Inhibitor | 98.64% | Unkown |
| HY-P0271A | Syntide 2 TFA | 99.70% | Unkown | |
| HY-P1076A | CALP2 TFA | Antagonist | 98.31% | Unkown |
| HY-P1080 | ω-Agatoxin IVA | Inhibitor | 98.71% | Unkown |
| HY-P1247 | Calcineurin autoinhibitory peptide | Inhibitor | 99.99% | Unkown |
| HY-P3187 | exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21 | / | Unkown | |
| HY-105118A | Zaldaride maleate | Antagonist | 99.7% | Unkown |
| HY-103544 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | 98.48% | Unkown | |
| HY-108592 | UCL 2077 | Inhibitor | 98.91% | Unkown |
| HY-110292 | A-425619 | 99.96% | Unkown | |
| HY-111527 | PPZ2 | 99.92% | Unkown | |
| HY-121584 | Lycoperodine-1 | Agonist | 99.82% | Unkown |
| HY-124594 | CA inhibitor 1 | Inhibitor | 99.77% | Unkown |
| HY-125703 | Ferutinin | 99.23% | Unkown | |
| HY-136182 | YM-244769 dihydrochloride | Inhibitor | 98.57% | Unkown |
| HY-136182A | YM-244769 | Inhibitor | 99.22% | Unkown |
| HY-136980 | Aspartylglutamate | 99.79% | Unkown | |
| HY-155480 | PSB-22034 | Agonist | 99.61% | Unkown |
| HY-15809 | (Rac)-Ibrutinib alkyne | Inhibitor | 99.35% | Unkown |
| HY-B0265A | (R)-Nimodipine | Antagonist | 99.87% | Unkown |
| HY-B0782S | Acetazolamide-d3 | Inhibitor | 99.9% | Unkown |
| HY-E70234A | Sortase A, S. aureus (non-Ca2+-dependent) | 96.90% | Unkown | |
| HY-N1940 | β-Anhydroicaritin | Inhibitor | 99.69% | Unkown |
| HY-N2157 | Pteryxin | Inhibitor | 99.55% | Unkown |
| HY-NP164B | Concanavalin A-AF488 | / | Unkown | |
| HY-P2757 | Phosphorylase kinase | / | Unkown | |
| HY-P3617 | Glucagon (22-29) | Agonist | 98.12% | Unkown |
| HY-41076 | Ca2+ channel agonist 1 | 98.87% | Unkown | |
| HY-D0077 | 2',7'-Difluorofluorescein | 99.52% | Unkown | |
| HY-N0742 | Absinthin | Agonist | 98.0% | Unkown |
| HY-165607S | MCB-22-174 | 99.78% | Unkown | |
| HY-103277A | BIM 23042 TFA | Antagonist | 99.75% | Unkown |
| HY-103317A | NAADP tetrasodium | 99.1% | Unkown | |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-12550 | GW542573X | Activator | 99.79% | Unkown |
| HY-126583 | Nemadipine-A | Inhibitor | 98.87% | Unkown |
| HY-130368 | W-7 | 99.35% | Unkown | |
| HY-136190 | TRPC6-PAM-C20 | Agonist | 99.78% | Unkown |
| HY-149483 | CVN417 | Antagonist | 99.93% | Unkown |
| HY-A0236A | Aprindine hydrochloride | Inhibitor | 98.96% | Unkown |
| HY-D0121A | INDO 1 pentapotassium | 96.43% | Unkown | |
| HY-N7117 | 1,4-Cineole | Activator | 95.0% | Unkown |
| HY-P0256A | Apamin TFA | Inhibitor | 97.49% | Unkown |
| HY-P3037A | Imperatoxin A TFA | Activator | 98.25% | Unkown |
| HY-P4160 | PDC31 | Inhibitor | 98.67% | Unkown |
| HY-W013857 | Lavendustin C | Inhibitor | 98.17% | Unkown |
| HY-W854385A | Sialyl Lewis A sodium | / | Unkown | |
| HY-100928 | YS 035 hydrochloride | Antagonist | 99.15% | Unkown |
| HY-107859S | Tris(2-chloroethyl)phosphate-d12 | 99.15% | Unkown | |
| HY-137172 | ETH 157 | 99.52% | Unkown | |
| HY-103320B | (1R,2R)-Calhex 231 hydrochloride | Control | 98.45% | Unkown |
| HY-10388A | TTA-Q6(isomer) | 99.91% | Unkown | |
| HY-107855S | DL-Mevalonolactone-d7 | 99.27% | Unkown | |
| HY-110140 | (E)-KN-93 phosphate | Inhibitor | 99.85% | Unkown |
| HY-119282 | AZD6538 | Inhibitor | / | Unkown |
| HY-121825 | U-44069 | Control | 98.0% | Unkown |
| HY-129496 | NP-313 | Inhibitor | 99.31% | Unkown |
| HY-131012 | GoSlo-SR-5-69 | Activator | 99.26% | Unkown |
| HY-13338 | Mabuterol | Agonist | 99.96% | Unkown |
| HY-151917 | Enpp/Carbonic anhydrase-IN-2 | Inhibitor | 98.48% | Unkown |
| HY-170360 | UCB9386 | Inhibitor | 99.89% | Unkown |
| HY-174140 | VU0514009 | Antagonist | 99.53% | Unkown |
| HY-175593 | M6766 | 99.43% | Unkown | |
| HY-176550 | ASIC1a antagonist-1 | Antagonist | 98.00% | Unkown |
| HY-176710 | PAD-PF2 | 99.94% | Unkown | |
| HY-18071A | BI-9627 hydrochloride | Inhibitor | 98.01% | Unkown |
| HY-B0246S4 | Carbamazepine-d4 | 99.72% | Unkown | |
| HY-N9404 | 6-Benzoylheteratisine | Inhibitor | 99.58% | Unkown |
| HY-P1079 | ω-Agatoxin TK | Inhibitor | ≥99.0% | Unkown |
| HY-P11205A | Cys-PKHB1 TFA | Activator | 99.43% | Unkown |
| HY-P1250 | RFRP-3(human) | Agonist | 99.43% | Unkown |
| HY-P1387 | β-Amyloid (1-40) (rat) | Inducer | / | Unkown |
| HY-W134005 | Mg(Ⅱ)-EDTA disodium tetrahydrate | 99.16% | Unkown | |
| HY-W641445 | ELP-004 | Inhibitor | 99.89% | Unkown |
| HY-100656AS | Desmethyl cariprazine-d8 | 99.93% | Unkown | |
| HY-126789A | DM-Nitrophen tertasodium | 90.0% | Unkown | |
| HY-W010252 | N-Benzylethylenediamine | 99.79% | Unkown | |
| HY-W1113135 | Carboxymethyl-β-cyclodextrin sodium salt | 99.6% | Unkown | |
| HY-14656S | Diltiazem-d3 hydrochloride | Antagonist | 98.70% | Unkown |
| HY-100402 | CFMTI | Antagonist | 98.0% | Unkown |
| HY-101390 | (+)-Niguldipine hydrochloride | Ligand | 98.06% | Unkown |
| HY-103078 | I-XW-053 | Inhibitor | 99.71% | Unkown |
| HY-103472 | FPR-A14 | Agonist | 98.58% | Unkown |
| HY-11000A | CaMKP inhibitor sodium | Inhibitor | 98.06% | Unkown |
| HY-111014 | VK-II-36 | Activator | 99.62% | Unkown |
| HY-115767 | (±)-1,2-Diolein | Activator | 97.0% | Unkown |
| HY-131041 | Ned-K | 99.35% | Unkown | |
| HY-145384 | ROC-0929 | Inhibitor | 99.62% | Unkown |
| HY-147005 | piCRAC-1 | Inhibitor | 99.36% | Unkown |
| HY-155516 | KV1.3-IN-1 | Inhibitor | 98.34% | Unkown |
| HY-15705 | GPR35 agonist 2 | 98.61% | Unkown | |
| HY-165473 | Hexadecylphosphoserine | Activator | / | Unkown |
| HY-165473A | Hexadecylphosphoserine TFA | Activator | 98.0% | Unkown |
| HY-173537 | D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt | 98.0% | Unkown | |
| HY-176745 | SW016789 | Inducer | 99.85% | Unkown |
| HY-76779 | 4-(Chloromethyl)-7-hydroxycoumarin | 98.01% | Unkown | |
| HY-B0493S1 | Niflumic acid-13C6 | Inhibitor | 99.8% | Unkown |
| HY-B1221S1 | Flufenamic acid-13C6 | / | Unkown | |
| HY-D1631 | Calcium Green-5N AM | / | Unkown | |
| HY-DY1095 | Fluo-3AM (solution) | / | Unkown | |
| HY-N0126R | Xanthone (Standard) | Inhibitor | 99.99% | Unkown |
| HY-N0215S14 | L-Phenylalanine-15N,d8 | Antagonist | 99.90% | Unkown |
| HY-N4237 | Saikogenin D | 99.99% | Unkown | |
| HY-N5130 | Effusol | Inhibitor | 99.83% | Unkown |
| HY-P1077 | CALP1 | 98.44% | Unkown | |
| HY-P11292 | Caloxin 1b3 | Inhibitor | 99.81% | Unkown |
| HY-P1397A | RVD-Hpα TFA | Agonist | 98.92% | Unkown |
| HY-P1640 | (Trp63,Trp64)-C3a(63-77) | Agonist | 99.23% | Unkown |
| HY-P1805 | Calmodulin Binding Peptide 1 | Ligand | 98.68% | Unkown |
| HY-P3811A | Autocamtide-3 acetate | 99.95% | Unkown | |
| HY-P5142A | ω-Hexatoxin-Hv1a TFA | Inhibitor | 97.49% | Unkown |
| HY-P6292 | KS-133 | 98.75% | Unkown | |
| HY-RS01776 | CA9 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS11007 | PPP2CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010221 | Phenyltrimethylammonium hydroxide | 98.0% | Unkown | |
| HY-W748509 | Pipernonaline | 99.30% | Unkown | |
| HY-101329S | Anthracene-9-carboxylic acid-d9 | 98.94% | Unkown | |
| HY-126789 | DM-Nitrophen | 98.40% | Unkown | |
| HY-154924 | Thio-NADP | 96.57% | Unkown | |
| HY-15515R | SEA0400 (Standard) | Inhibitor | 98.11% | Unkown |
| HY-N16129 | Diplacone | 98.38% | Unkown | |
| HY-N4308 | Hexamethylquercetagetin | Inhibitor | 98.0% | Unkown |
| HY-RS10523 | PIK3CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W587805 | Perfluorohexane sulfonamide | Inhibitor | / | Unkown |
| HY-Y0258S | Benzocaine-d4 | 99.34% | Unkown | |
| HY-B0124S | Zonisamide-d4 | Inhibitor | 99.38% | Unkown |
| HY-101902 | Quin-2AM | / | Unkown | |
| HY-100718 | SCH00013 | Activator | / | Unkown |
| HY-101015 | (2E)-OBAA | / | Unkown | |
| HY-101428 | NS-638 | Inhibitor | 99.84% | Unkown |
| HY-101693A | Senazodan hydrochloride | Inhibitor | 99.84% | Unkown |
| HY-103308 | TRAM-39 | Inhibitor | 99.66% | Unkown |
| HY-10388 | TTA-Q6 | Antagonist | 99.97% | Unkown |
| HY-104056 | Fura Red | / | Unkown | |
| HY-106784A | (E)-Ajoene | 95% | Unkown | |
| HY-107659 | YM-244769 hydrochloride | Inhibitor | 98.09% | Unkown |
| HY-107678 | SEN12333 | Agonist | 98.45% | Unkown |
| HY-108515 | (+)-Igmesine hydrochloride | 99.0% | Unkown | |
| HY-112741 | SB-209247 | Antagonist | 99.33% | Unkown |
| HY-113970A | Nebracetam hydrochloride | 99.0% | Unkown | |
| HY-115745 | Calmodulin antagonist-1 | Antagonist | 98.0% | Unkown |
| HY-120514 | JNc-440 | 98.04% | Unkown | |
| HY-120528 | GB-110 | Agonist | / | Unkown |
| HY-121604 | (Rac)-MEM 1003 | Inhibitor | 99.64% | Unkown |
| HY-129146S | Doxapram-d5 hydrochloride | Inhibitor | 99.0% | Unkown |
| HY-131040 | NLRP3-IN-NBC6 | Inhibitor | 99.40% | Unkown |
| HY-131948 | 3-Chlorodiphenylamine | Activator | 98.74% | Unkown |
| HY-132190 | Hexanolamino PAF C-16 | Antagonist | 99.9% | Unkown |
| HY-132239 | 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate | 99.58% | Unkown | |
| HY-135110 | Rp-8-Br-cGMPS sodium | 99.9% | Unkown | |
| HY-13617 | Edatrexate | / | Unkown | |
| HY-136395 | Cartap | Inducer | / | Unkown |
| HY-13699 | NBI-42902 | 98.65% | Unkown | |
| HY-141712 | ZA18 | Inhibitor | 99.72% | Unkown |
| HY-147377 | N-Salicyloyltryptamine | 96.37% | Unkown | |
| HY-147384 | CXL-1020 | ≥99.0% | Unkown | |
| HY-148135 | hCAI/II-IN-6 | Inhibitor | 98.0% | Unkown |
| HY-149301 | hCAIX-IN-18 | Inhibitor | 98.52% | Unkown |
| HY-151916 | Enpp/Carbonic anhydrase-IN-1 | 99.57% | Unkown | |
| HY-15293 | JTV-519 | Inhibitor | 98.0% | Unkown |
| HY-15671A | GKA50 quarterhydrate | Activator | ≥98.0% | Unkown |
| HY-16489A | Terodiline hydrochloride | Antagonist | 99.78% | Unkown |
| HY-19857 | Sulcardine sulfate | / | Unkown | |
| HY-B0561S4 | Spironolactone-d6-1 | 99.26% | Unkown | |
| HY-B1837A | β-Cyfluthrin | Inhibitor | 99.94% | Unkown |
| HY-B1873 | Methoxychlor | Inducer | 99.41% | Unkown |
| HY-DY1101 | Fura-2 AM (solution) | / | Unkown | |
| HY-N0252A | Catharanthine Tartrate | Inhibitor | 98.88% | Unkown |
| HY-N0252B | Catharanthine Sulfate | Inhibitor | / | Unkown |
| HY-N10116A | Calamenene | / | Unkown | |
| HY-N10772 | Albanin A | Inhibitor | 97.67% | Unkown |
| HY-N1989 | Bacoside A | / | Unkown | |
| HY-N2359 | Chelerythrine | / | Unkown | |
| HY-N4267 | Yangambin | 98.27% | Unkown | |
| HY-N7875 | Celangulin | 95.93% | Unkown | |
| HY-NP164L | Concanavalin A-AF647 | / | Unkown | |
| HY-P0271 | Syntide 2 | / | Unkown | |
| HY-P1479A | Calmodulin-Dependent Protein Kinase II(290-309) acetate | 98.45% | Unkown | |
| HY-P3037 | Imperatoxin A | Activator | / | Unkown |
| HY-P3965A | 16-38-Thymosin β4 (cattle) TFA | Activator | 98.14% | Unkown |
| HY-P5154A | Tamapin TFA | Antagonist | 98.79% | Unkown |
| HY-P5914 | Wasabi Receptor Toxin | Activator | / | Unkown |
| HY-P5914A | Wasabi Receptor Toxin TFA | Activator | 99.49% | Unkown |
| HY-P5988 | N-myristoyl-RKRTLRRL | Inhibitor | 99.37% | Unkown |
| HY-P6013A | wt hMLN TFA | Inhibitor | 95.0% | Unkown |
| HY-Q40876 | BBT | Modulator | 99.71% | Unkown |
| HY-W170020 | PTCA | Ligand | 99.72% | Unkown |
| HY-W250149 | Chlorophosphonazo III | / | Unkown | |
| HY-W854385 | Sialyl Lewis A | / | Unkown | |
| HY-Y0258R | Benzocaine (Standard) | 99.99% | Unkown | |
| HY-Y0258S1 | Benzocaine-(ethyl-d5) | 99.0% | Unkown | |
| HY-Y1422E | Lipase,Aspergillusniger (Immobilized) | / | Unkown | |
| HY-101693 | Senazodan | Inhibitor | / | Unkown |
| HY-12962 | NMDA-IN-1 | Antagonist | 98.98% | Unkown |
| HY-132191 | Pradimicin A | Inhibitor | / | Unkown |
| HY-134261A | 8-Br-ADPR disodium | Inhibitor | / | Unkown |
| HY-150135B | D-myo-Inositol 1,4,5-trisphosphate tripotassium | Activator | 98.00% | Unkown |
| HY-70037AS | Cinacalcet-d3 hydrochloride | Agonist | 97.63% | Unkown |
| HY-B1193S | Terfenadine-d3 | / | Unkown | |
| HY-B2217D | Calcium hydroxide, ACS, 95% | Inhibitor | / | Unkown |
| HY-I0096R | Indole-2-carboxylic acid (Standard) | Inhibitor | 99.78% | Unkown |
| HY-N0215S | L-Phenylalanine-d7 | Antagonist | 99.90% | Unkown |
| HY-RS21174 | Ppp2ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011235S | Norfluoxetine-d5 hydrochloride | 99.30% | Unkown | |
| HY-W654243 | Isovalerylcarnitine-d9-1 chloride | Activator | 99.55% | Unkown |
| HY-111207 | CA224 | 99.94% | Unkown | |
| HY-114400A | TRPV4 agonist-1 | Agonist | / | Unkown |
| HY-169964 | TSPO/Carbonic Anhydrase Modulator 1 | Modulator | / | Unkown |
| HY-B0551S | Doxapram-d8 | Inhibitor | 99.54% | Unkown |
| HY-B0782S1 | Acetazolamide-13C2,d3 | / | Unkown | |
| HY-100424 | PI3K-IN-63 | Inhibitor | / | Unkown |
| HY-102085 | 11-Deoxyglycyrrhetinic acid sodium | Activator | / | Unkown |
| HY-103309A | ML218 hydrochloride | Inhibitor | / | Unkown |
| HY-125836 | CCR4 antagonist 2 | Antagonist | / | Unkown |
| HY-184055 | NMDA receptor antagonist-12 | Antagonist | / | Unkown |
| HY-19805A | STO-609 acetate | Inhibitor | / | Unkown |
| HY-N1584B | Halofuginone hydrochloride | / | Unkown | |
| HY-135556AS | Norfluoxetine-d5 | / | Unkown | |
| HY-B0632S | Diltiazem-d6 | Antagonist | / | Unkown |
| HY-N1369S | Menthol-d4 | / | Unkown | |
| HY-P2471 | Neurogranin (48-76), mouse | Inhibitor | / | Unkown |
| HY-10050 | CJ-17493 | Antagonist | / | Unkown |
| HY-100783A | (+)-Bicuculline methochloride | Antagonist | / | Unkown |
| HY-100783B | Bicuculline methobromide | Antagonist | / | Unkown |
| HY-100843 | L-AP6 | / | Unkown | |
| HY-100981 | MR-16728 hydrochloride | / | Unkown | |
| HY-10167 | Tecalcet | Modulator | / | Unkown |
| HY-101685A | Iganidipine dihydrochloride | Antagonist | / | Unkown |
| HY-103078A | I-XW-053 sodium | Inhibitor | / | Unkown |
| HY-103277 | BIM 23042 | Antagonist | / | Unkown |
| HY-103309S | ML218-d9 | Inhibitor | / | Unkown |
| HY-103313 | SR33805 oxalate | Antagonist | / | Unkown |
| HY-103320 | Calhex 231 | Antagonist | / | Unkown |
| HY-103545 | GIP (1-39) | Agonist | / | Unkown |
| HY-103660S | 18:0 LYSO-PE-d35 | / | Unkown | |
| HY-105118 | Zaldaride | Inhibitor | / | Unkown |
| HY-105402 | T 162559 | Inhibitor | / | Unkown |
| HY-105415 | U 92032 | Inhibitor | / | Unkown |
| HY-106428 | Icrocaptide | Inhibitor | / | Unkown |
| HY-106525 | Aclatonium napadisylate | Agonist | / | Unkown |
| HY-106761 | Oxodipine | Antagonist | / | Unkown |
| HY-106818A | Monatepil maleate | / | Unkown | |
| HY-106837 | Israpafant | Antagonist | / | Unkown |
| HY-107855S1 | DL-Mevalonolactone-d3 | / | Unkown | |
| HY-108163A | SB-237376 | / | Unkown | |
| HY-108659 | NF340 | / | Unkown | |
| HY-109056A | Elsulfavirine sodium | Inhibitor | / | Unkown |
| HY-109106B | (Rac)-Upacicalcet | 95.0% | Unkown | |
| HY-110023R | Zimelidine dihydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-111198 | YM-355179 fumarate | / | Unkown | |
| HY-111214 | K-14585 | / | Unkown | |
| HY-111964S1 | Lenacapavir-d5 | Inhibitor | / | Unkown |
| HY-112393 | TX-1918 | Inhibitor | / | Unkown |
| HY-113658 | ts-SA | / | Unkown | |
| HY-113920 | Azumolene sodium | Inhibitor | / | Unkown |
| HY-114554 | KS 619-1 | Inhibitor | / | Unkown |
| HY-114691 | R 59494 | Inhibitor | / | Unkown |
| HY-114743 | GS 283 | Antagonist | / | Unkown |
| HY-114826 | Prostaglandin E2-1-glyceryl ester | Activator | / | Unkown |
| HY-114990 | EMD 57439 | Inhibitor | / | Unkown |
| HY-115493 | TIQ-15 | Antagonist | / | Unkown |
| HY-115998 | Carbonic anhydrase inhibitor 11 | Inhibitor | / | Unkown |
| HY-115999 | Carbonic anhydrase inhibitor 12 | Inhibitor | / | Unkown |
| HY-116153 | HUHS2002 | / | Unkown | |
| HY-116312 | 8-pCPT-2′-O-Me-cAMP | Activator | / | Unkown |
| HY-116330 | Hyperforin | / | Unkown | |
| HY-116429A | 7(S)-Maresin 1 | / | Unkown | |
| HY-116429S | Maresin 1-d5 | Inhibitor | / | Unkown |
| HY-116500A | AH-1058 | Antagonist | / | Unkown |
| HY-116540 | L 858051 | Activator | / | Unkown |
| HY-116540A | L 858051 dihydrochloride | Activator | / | Unkown |
| HY-117099 | TMB-8 | Antagonist | 98.0% | Unkown |
| HY-117578 | KB 5666 | / | Unkown | |
| HY-118817 | Evariquinone | Inhibitor | / | Unkown |
| HY-118835 | Zimelidine | Inhibitor | / | Unkown |
| HY-119386 | SAS-0132 | / | Unkown | |
| HY-119850A | Aladorian sodium | Modulator | / | Unkown |
| HY-119919 | Clofenamide | Inhibitor | / | Unkown |
| HY-120321 | DSR-71167 | / | Unkown | |
| HY-120699 | RO5488608 | Modulator | / | Unkown |
| HY-120764 | PF-46396 | Inhibitor | / | Unkown |
| HY-120820 | LY320954 | Antagonist | / | Unkown |
| HY-120985 | Araguspongin B | Antagonist | / | Unkown |
| HY-121235S1 | Clonixin-13C,d3 | Inhibitor | / | Unkown |
| HY-121299 | m-Chlorophenylbiguanide | ≥90.0% | Unkown | |
| HY-121516 | CM-TPMF | / | Unkown | |
| HY-12153 | JNJ-1930942 | Modulator | / | Unkown |
| HY-12155 | JNJ-26990990 | Inhibitor | / | Unkown |
| HY-121690 | Semotiadil | Antagonist | / | Unkown |
| HY-121966 | Riparin | 98.00% | Unkown | |
| HY-12292G | IM-12 (GMP) | / | Unkown | |
| HY-123659 | KR-33028 | Inhibitor | / | Unkown |
| HY-124176 | L-6355 | / | Unkown | |
| HY-124985 | VU6010608 | Modulator | / | Unkown |
| HY-12542S | Dantrolene-13C3 | Inhibitor | 99.0% | Unkown |
| HY-125641A | AL-34662 formate | Agonist | / | Unkown |
| HY-12596 | JNJ-26489112 | 99.31% | Unkown | |
| HY-126821 | Fluo-3 | / | Unkown | |
| HY-126821A | Fluo-3 pentaammonium | / | Unkown | |
| HY-128547 | Cetiedil citrate | / | Unkown | |
| HY-129088 | HUP30 | 99.68% | Unkown | |
| HY-129547 | Fluo-3 pentapotassium | / | Unkown | |
| HY-12962A | NMDA-IN-1 dihydrochloride | Antagonist | / | Unkown |
| HY-129781 | L-650719 | Inhibitor | / | Unkown |
| HY-130070 | QO-40 | Activator | 98.77% | Unkown |
| HY-131001 | DPNB-ABT594 | Agonist | / | Unkown |
| HY-131691 | NMDAR blocker 1 | / | Unkown | |
| HY-131942 | sFTX-3.3 | Antagonist | / | Unkown |
| HY-132227 | Dichlorobenzamil hydrochloride | Inhibitor | / | Unkown |
| HY-133596 | 12,14-Dichlorodehydroabietic acid | / | Unkown | |
| HY-134261 | 8-Br-ADPR | Inhibitor | / | Unkown |
| HY-135433 | MAPTAM | / | Unkown | |
| HY-135478 | LY393615 | Inhibitor | / | Unkown |
| HY-135601 | Cinacalcet metabolite M4 | / | Unkown | |
| HY-135746S | OR-1896-d3 | / | Unkown | |
| HY-136189 | UK-59811 hydrochloride | Inhibitor | / | Unkown |
| HY-136283 | DMNPE-4 AM-caged-calcium | Ligand | / | Unkown |
| HY-136894 | Rhod-5N | / | Unkown | |
| HY-137203 | (+)-Niguldipine | / | Unkown | |
| HY-13764A | dl-Tetrandrine | Inhibitor | / | Unkown |
| HY-137952 | NS8593 | Inhibitor | / | Unkown |
| HY-138302 | PF-06862309 | / | Unkown | |
| HY-138951 | AY77 | Agonist | / | Unkown |
| HY-138990 | GK563 | Inhibitor | / | Unkown |
| HY-139041 | Palmitoylcholine chloride | Inhibitor | 99.52% | Unkown |
| HY-139145 | Etbicyphat | Antagonist | 98.0% | Unkown |
| HY-139145S | Etbicyphat-13C3 | / | Unkown | |
| HY-141564 | RyR1-IN-1 | Inhibitor | / | Unkown |
| HY-141713 | ZA10 | Inhibitor | / | Unkown |
| HY-142050 | (R)-IDHP | / | Unkown | |
| HY-142087 | Beauverolide Ja | Inhibitor | / | Unkown |
| HY-142117 | Adenophostin A | Activator | / | Unkown |
| HY-143460 | CAXII-IN-1 | Inhibitor | / | Unkown |
| HY-144222 | NSC 828467 | Inhibitor | / | Unkown |
| HY-144807 | Carbonic anhydrase inhibitor 9 | Inhibitor | / | Unkown |
| HY-145196 | RTICBM-189 | Modulator | 99.73% | Unkown |
| HY-145385 | Coelenteramide | / | Unkown | |
| HY-145900 | S100A2-p53-IN-1 | Inhibitor | / | Unkown |
| HY-146010 | Carbonic anhydrase inhibitor 13 | Inhibitor | / | Unkown |
| HY-146232 | F 13714 | Agonist | / | Unkown |
| HY-146252 | hCAXII-IN-4 | Inhibitor | / | Unkown |
| HY-146259 | hCAIX/XII-IN-4 | Inhibitor | / | Unkown |
| HY-146461 | Anticancer agent 58 | / | Unkown | |
| HY-146462 | Anticancer agent 59 | / | Unkown | |
| HY-14656S1 | Diltiazem-(acetoxy-d3) hydrochloride | Antagonist | / | Unkown |
| HY-14656S4 | Diltiazem-d4-1 hydrochloride | Antagonist | / | Unkown |
| HY-146819 | CAIX/CAXII-IN-1 | / | Unkown | |
| HY-146982 | hCAII-IN-1 | Inhibitor | / | Unkown |
| HY-146983 | hCAIX-IN-3 | Inhibitor | / | Unkown |
| HY-147186 | 5,5'-Difluoro BAPTA | / | Unkown | |
| HY-147383 | NS-8 | Activator | / | Unkown |
| HY-149011 | CA IX-IN-1 | Inhibitor | / | Unkown |
| HY-149342 | α-Glucosidase-IN-29 | Inhibitor | / | Unkown |
| HY-150039 | CCG-271423 | Inhibitor | / | Unkown |
| HY-15016 | (E/Z)-OT-R antagonist 1 | Antagonist | / | Unkown |
| HY-15018A | SSR126768A free base | Antagonist | / | Unkown |
| HY-150536 | EP39 | Inhibitor | / | Unkown |
| HY-150570 | Carbonic anhydrase inhibitor 14 | Inhibitor | / | Unkown |
| HY-150695 | hCAIX/XII-IN-5 | / | Unkown | |
| HY-150782 | UNC-CA359 | Inhibitor | / | Unkown |
| HY-151451 | Cav 3.2 inhibitor 2 | Inhibitor | / | Unkown |
| HY-151452 | Cav 3.2 inhibitor 3 | Inhibitor | / | Unkown |
| HY-151472 | hCAIX/XII-IN-6 | Inhibitor | / | Unkown |
| HY-151493 | CAII-IN-1 | Inhibitor | / | Unkown |
| HY-151494 | CAII-IN-2 | Inhibitor | / | Unkown |
| HY-151495 | CAII-IN-3 | Inhibitor | / | Unkown |
| HY-151547 | MRS4719 | Antagonist | / | Unkown |
| HY-151547S | MRS4719-d3 | / | Unkown | |
| HY-151578 | DPP IV/hCA II-IN-1 | Inhibitor | / | Unkown |
| HY-151633 | hCAIX-IN-14 | Inhibitor | / | Unkown |
| HY-152140 | hCAII-IN-8 | Inhibitor | 99.41% | Unkown |
| HY-155694 | hCA/VEGFR-2-IN-1 | Inhibitor | / | Unkown |
| HY-156013 | CA inhibitor 2 | Inhibitor | / | Unkown |
| HY-156082 | RyRs activator 3 | Inhibitor | / | Unkown |
| HY-156104 | CaMKIIα-PHOTAC | Degrader | / | Unkown |
| HY-156181 | hCAIX/XII-IN-8 | Inhibitor | / | Unkown |
| HY-157139 | ALP/Carbonic anhydrase-IN-1 | Inhibitor | 99.90% | Unkown |
| HY-158328A | CA IX/VEGFR-2-IN-2 | / | Unkown | |
| HY-159122 | CA IX-IN-2 | / | Unkown | |
| HY-159861 | Ionizable Lipid 4 | / | Unkown | |
| HY-159870 | E12CA1A3 | / | Unkown | |
| HY-160099S | 20-5,14-HEDE-d2 | / | Unkown | |
| HY-160099S1 | 20-5,14-HEDE-d2-1 | / | Unkown | |
| HY-160099S2 | 20-5,14-HEDE-d2-2 | / | Unkown | |
| HY-160508 | NCX1-IN-1 | Inhibitor | / | Unkown |
| HY-160962 | SM1044 | / | Unkown | |
| HY-160998 | YM-344031 | Antagonist | / | Unkown |
| HY-161143 | Carbonic anhydrase/AChE-IN-2 | Inhibitor | / | Unkown |
| HY-161388 | NSCLC-IN-1 | Inducer | / | Unkown |
| HY-162000 | hCAIX/XII-IN-13 | Inducer | / | Unkown |
| HY-162005 | AChE-IN-48 | Inhibitor | / | Unkown |
| HY-162063 | hCAIX/XII-IN-9 | Inhibitor | / | Unkown |
| HY-162280 | PROTAC BTK Degrader-9 | / | Unkown | |
| HY-162331 | STING Degrader-1 | Degrader | / | Unkown |
| HY-162344 | Ir-CA | Inducer | / | Unkown |
| HY-162374 | ANO61 | Inhibitor | / | Unkown |
| HY-162375 | AF299 | / | Unkown | |
| HY-162521 | Antibacterial agent 215 | Inhibitor | / | Unkown |
| HY-162526 | HIV capsid modulator 2 | Modulator | / | Unkown |
| HY-162774 | GRP75-IN-1 | Inducer | / | Unkown |
| HY-163116 | Anti-inflammatory agent 67 | Inhibitor | / | Unkown |
| HY-163117 | Anti-inflammatory agent 68 | Inhibitor | / | Unkown |
| HY-163380 | CA/MAO-B-IN-1 | Inhibitor | 98.34% | Unkown |
| HY-164682 | AMD 3329 octahydrobromide | Inhibitor | / | Unkown |
| HY-164684 | Dichlorobenzamil | Inhibitor | / | Unkown |
| HY-165492 | Opc 14117 | Inhibitor | / | Unkown |
| HY-165569 | AU-1421 | Modulator | / | Unkown |
| HY-166363S | Beraprost-d3 | / | Unkown | |
| HY-166562S | Levomepromazine-d6 hydrochloride | / | Unkown | |
| HY-167091 | (Rac)-Beraprost | / | Unkown | |
| HY-168320 | N-Stearoyltyrosine | Inhibitor | / | Unkown |
| HY-168603 | AChE/CA I-IN-1 | Inhibitor | / | Unkown |
| HY-168604 | CA Ⅱ-IN-1 | Inhibitor | / | Unkown |
| HY-169115A | (Rac)-PD0299685 | Ligand | / | Unkown |
| HY-169162 | hBChE-IN-3 | / | Unkown | |
| HY-169209 | CA-M11 | Inhibitor | / | Unkown |
| HY-169845 | Calcium Channel antagonist 6 | Antagonist | / | Unkown |
| HY-170424 | D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium | / | Unkown | |
| HY-170541 | FUT8-IN-1 | Inhibitor | / | Unkown |
| HY-170551 | CA IX/VEGFR-2-IN-3 | Inhibitor | / | Unkown |
| HY-170558 | FW-1 | / | Unkown | |
| HY-170560 | AChE/hCA I-IN-1 | Inhibitor | / | Unkown |
| HY-170801 | Anticonvulsant agent 7 | Control | / | Unkown |
| HY-170893 | CAIX/CAXII-IN-4 | Inhibitor | / | Unkown |
| HY-171129 | EP055 | / | Unkown | |
| HY-172772 | Anti-PEDV agent 1 | Inhibitor | / | Unkown |
| HY-172899 | Carbonic anhydrase inhibitor 33 | / | Unkown | |
| HY-172950 | CAXII-IN-2 | Inhibitor | / | Unkown |
| HY-172964 | KIM-161 | / | Unkown | |
| HY-173194 | Carbonic anhydrase inhibitor 29 | Inhibitor | / | Unkown |
| HY-173321 | PAD4-IN-5 | Inhibitor | / | Unkown |
| HY-173618 | LQFM020 | / | Unkown | |
| HY-17404S | Cilnidipine-d7 | Inhibitor | / | Unkown |
| HY-174232 | EGFR/CA-IX-IN-1 | / | Unkown | |
| HY-174269 | HIV Capsid-IN-2 | Inhibitor | / | Unkown |
| HY-174835 | hCA-I/hCA-II-IN-1 | Inhibitor | / | Unkown |
| HY-175021 | HDAC-IN-91 | / | Unkown | |
| HY-175219 | CA-II/Dkk1-IN-1 | Inhibitor | / | Unkown |
| HY-175441 | Carbonic anhydrase activator 1 | Activator | / | Unkown |
| HY-175638 | Carbonic anhydrase-IN-35 | / | Unkown | |
| HY-175675 | P2Y1 antagonist 4 | / | Unkown | |
| HY-176021 | U-44069 serinol amide | / | Unkown | |
| HY-176041 | Troponin modulator 1 | / | Unkown | |
| HY-176147 | Apoptosis inducer 38 | Inducer | / | Unkown |
| HY-177091 | AS2795440 | Inhibitor | / | Unkown |
| HY-177296 | GPR40 agonist 8 | Agonist | / | Unkown |
| HY-177573 | Cholesteryl γ-aminobutyrate | / | Unkown | |
| HY-178030 | CAXII-IN-3 | / | Unkown | |
| HY-178144 | FPR2 agonist 5 | / | Unkown | |
| HY-178251S | L-Phenylalanine-d | / | Unkown | |
| HY-178437 | Bastadins-5 | / | Unkown | |
| HY-178475 | CA IX/GPX4-IN-1 | / | Unkown | |
| HY-178963 | Nav1.2-IN-2 | Inhibitor | 99.82% | Unkown |
| HY-179016 | Ferroptosis/apoptosis inducer-3 | / | Unkown | |
| HY-179022 | CAIX/CDK-2-IN-1 | / | Unkown | |
| HY-179034 | CAIX/XII-IN-16 | / | Unkown | |
| HY-179271 | CA/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-179387 | CXCR2-IN-3 | / | Unkown | |
| HY-179439 | Multi-kinase-IN-8 | / | Unkown | |
| HY-179530 | CA-II/TNAP-IN-1 | Inhibitor | / | Unkown |
| HY-179712 | As-CA11 | / | Unkown | |
| HY-180056 | CAII-IN-12 | / | Unkown | |
| HY-180165 | Antiallergic agent-5 | Inhibitor | / | Unkown |
| HY-180189 | Carbonic anhydrase-IN-37 | Inhibitor | / | Unkown |
| HY-180194 | SERCA2a activator 2 | Activator | / | Unkown |
| HY-180244 | P2L-003 | / | Unkown | |
| HY-18051 | CXL 017 | / | Unkown | |
| HY-180891 | Multitarget AD-IN-4 | Inhibitor | / | Unkown |
| HY-181087 | Anticancer agent 296 | / | Unkown | |
| HY-181587 | PDGFRA/CAIX/XII-IN-1 | 98.10% | Unkown | |
| HY-181684 | PDE5/CA-IN-1 | Inhibitor | / | Unkown |
| HY-181755 | Phenylaminojuglone AJ-2 | Inhibitor | / | Unkown |
| HY-182007 | CA IX-IN-5 | Inhibitor | / | Unkown |
| HY-182068 | NFI23 | Inhibitor | / | Unkown |
| HY-182252 | SAR296968 | Inhibitor | / | Unkown |
| HY-182472 | AL-38022A | Agonist | / | Unkown |
| HY-182514 | BMMP | / | Unkown | |
| HY-182551 | SR-12062 | Agonist | / | Unkown |
| HY-182662 | Polymer blocking agent CA2000 | / | Unkown | |
| HY-182662A | Polymer blocking agent CA4000 | / | Unkown | |
| HY-182736 | YM-344484 | / | Unkown | |
| HY-183206 | UR 8225 | / | Unkown | |
| HY-183283 | CAII-IN-15 | Inhibitor | / | Unkown |
| HY-183549 | Ferroptosis/apoptosis inducer-4 | Inducer | / | Unkown |
| HY-183590 | CAIX/XII-IN-17 | / | Unkown | |
| HY-183591 | CAIX/XII-IN-18 | / | Unkown | |
| HY-183760 | AChE/BChE-IN-37 | Inhibitor | / | Unkown |
| HY-186165 | KARI 101 | / | Unkown | |
| HY-186172 | KS0365 | Activator | / | Unkown |
| HY-19025 | CV-159 | Antagonist | / | Unkown |
| HY-19044 | SKF 95601 | / | Unkown | |
| HY-19230 | DY-9760e | Inhibitor | / | Unkown |
| HY-19409 | AJG049 | Antagonist | / | Unkown |
| HY-204388 | TAK-137 | Agonist | / | Unkown |
| HY-34740S1 | Ethylmalonic acid-d5 | Inhibitor | 98.09% | Unkown |
| HY-44602 | Thioaspirine | Inhibitor | / | Unkown |
| HY-50876A | Daporinad hydrochloride | / | Unkown | |
| HY-70037S | Cinacalcet-d3 | Agonist | / | Unkown |
| HY-A0057AS2 | Gabapentin-d4 hydrochloride | Inhibitor | / | Unkown |
| HY-B0006CS | (R)-Carvedilol-d4 | Inhibitor | / | Unkown |
| HY-B0021S1 | Doxifluridine-d3 | Inhibitor | / | Unkown |
| HY-B0109AS1 | Dorzolamide-d5hydrochloride | Inhibitor | / | Unkown |
| HY-B0358AS | Flunarizine-d8 dihydrochloride | / | Unkown | |
| HY-B0380S1 | Trimebutine-d5 fumarate | / | Unkown | |
| HY-B0380S2 | Trimebutine-d3 hydrochloride | / | Unkown | |
| HY-B0549S | Flavoxate-d5 | / | Unkown | |
| HY-B0588AS | Brinzolamide-d5 hydrochloride | / | Unkown | |
| HY-B0596S | Taltirelin-13C,d3 | / | Unkown | |
| HY-B0684S1 | Iopamidol-d3 | / | Unkown | |
| HY-B1221S | Flufenamic acid-d4 | / | Unkown | |
| HY-B1693A | Levomepromazine hydrochloride | / | Unkown | |
| HY-B1726 | Phenacaine | Inhibitor | 99.68% | Unkown |
| HY-B1837AR | β-Cyfluthrin (Standard) | Inhibitor | / | Unkown |
| HY-CE01249 | CA-CoA | / | Unkown | |
| HY-D0121 | INDO 1 | / | Unkown | |
| HY-D0121B | INDO 1 pentasodium | / | Unkown | |
| HY-D0157 | ZnAF-2 | / | Unkown | |
| HY-D1424 | Coelenterazine hcp | / | Unkown | |
| HY-D1501 | Fura PE-3 potassium | / | Unkown | |
| HY-D1631A | Calcium green-5N hexapotassium | / | Unkown | |
| HY-D1636 | 5-Nitro BAPTA | / | Unkown | |
| HY-D1640 | 5',5-Difluoro BAPTA tetrapotassium | / | Unkown | |
| HY-D1643 | 5,5'-Dinitro BAPTA AM | / | Unkown | |
| HY-D1700 | Mag-indo-1/AM | / | Unkown | |
| HY-D1702 | Mag-Fura-2 tetrapotassium | / | Unkown | |
| HY-D1755 | Fluo-3FF AM | / | Unkown | |
| HY-D2952 | BOCA-1-BG | / | Unkown | |
| HY-D3030 | Concanavalin A-FITC | / | Unkown | |
| HY-D3031 | Concanavalin A-TRITC | / | Unkown | |
| HY-DY1055 | TSQ (solution) | / | Unkown | |
| HY-E70197 | Calpain-1 (pig) | / | Unkown | |
| HY-E70813 | CAMKK2 Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70856 | PKCθ Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70949 | Protein Kinase C,Rat | / | Unkown | |
| HY-E71159 | 1,4-Lactonase | / | Unkown | |
| HY-E71164 | 1,5-Anhydro-D-fructose dehydratase | / | Unkown | |
| HY-E71168 | 1,6-α-D-Mannosidase | / | Unkown | |
| HY-I0096S | Indole-2-carboxylic acid-13C | Inhibitor | / | Unkown |
| HY-N0043R | Ginsenoside Rd (Standard) | Inhibitor | / | Unkown |
| HY-N0215S13 | L-Phenylalanine-d1 | Antagonist | 99.5% | Unkown |
| HY-N0215S16 | L-Phenylalanine-13C-1 | / | Unkown | |
| HY-N0215S6 | DL-Phenylalanine-d5 hydrochloride | Antagonist | / | Unkown |
| HY-N0215S9 | L-Phenylalanine-13C9,15N,d8 | Antagonist | / | Unkown |
| HY-N0219R | Bicuculline (Standard) | Antagonist | / | Unkown |
| HY-N0392R | Polygalasaponin F (Standard) | Inhibitor | / | Unkown |
| HY-N10512 | Gangliotetraose | / | Unkown | |
| HY-N11887 | Linocinnamarin | Inhibitor | 99.14% | Unkown |
| HY-N1228 | Soyacerebroside I | / | Unkown | |
| HY-N12726 | Halociline | Inhibitor | / | Unkown |
| HY-N15735 | Cimicifugic acid D | Inhibitor | / | Unkown |
| HY-N15737 | Fukinolic acid | Inhibitor | / | Unkown |
| HY-N16525 | Muramine | / | Unkown | |
| HY-N17738 | Acetyljujuboside B | / | Unkown | |
| HY-N18114 | rel-(E)-6,7-Transdihydroxyligustilide | / | Unkown | |
| HY-N18121 | Taxinine A | / | Unkown | |
| HY-N18279 | Bulbocapnine | Antagonist | / | Unkown |
| HY-N18431 | Stellettamide A TFA | Inhibitor | / | Unkown |
| HY-N19827 | Monodesmoside saponin C | / | Unkown | |
| HY-N2359A | Chelerythrine hydroxide | / | Unkown | |
| HY-N2359S | Chelerythrine-d6 chloride | / | Unkown | |
| HY-N3729 | (-)-Denudatin B | Inhibitor | 97.88% | Unkown |
| HY-N6687C | Calcimycin hemicalcium hemimagnesium | / | Unkown | |
| HY-N7063R | Nerol (Standard) | / | Unkown | |
| HY-N7594 | Senecionine acetate | / | Unkown | |
| HY-N8112 | Polygalasaponin LII | / | Unkown | |
| HY-NP164A | Concanavalin A-Cy5.5 | / | Unkown | |
| HY-NP164C | Concanavalin A-AF350 | / | Unkown | |
| HY-NP164D | Concanavalin A-AF405 | / | Unkown | |
| HY-NP164E | Concanavalin A-AF430 | / | Unkown | |
| HY-NP164H | Concanavalin A-AF532 | / | Unkown | |
| HY-NP164I | Concanavalin A-AF546 | / | Unkown | |
| HY-NP164J | Concanavalin A-AF555 | / | Unkown | |
| HY-NP164K | Concanavalin A-AF568 | / | Unkown | |
| HY-NP164M | Concanavalin A-AF680 | / | Unkown | |
| HY-NP164N | Concanavalin A-Cy3 | / | Unkown | |
| HY-NP164O | Concanavalin A-Cy5 | / | Unkown | |
| HY-P0033A | Argireline acetate | Inhibitor | / | Unkown |
| HY-P0221A | PACAP (1-38), human, ovine, rat TFA | Inducer | / | Unkown |
| HY-P10316 | CaMKI(299-320) | Modulator | / | Unkown |
| HY-P10328 | Vasoactive intestinal contractor | Inhibitor | / | Unkown |
| HY-P1075A | CALP3 TFA | Inhibitor | / | Unkown |
| HY-P1076 | CALP2 | Antagonist | / | Unkown |
| HY-P10773 | CTP-amiodarone | Inhibitor | / | Unkown |
| HY-P10805 | Capsid assembly inhibitor | Inhibitor | / | Unkown |
| HY-P10811 | Na+-Ca2+ Exchanger | Inhibitor | / | Unkown |
| HY-P10972 | GIP (22-51) human | / | Unkown | |
| HY-P11019 | IS4 | Antagonist | / | Unkown |
| HY-P11082 | APGW-amide | / | Unkown | |
| HY-P11205 | Cys-PKHB1 | Activator | / | Unkown |
| HY-P11252 | DOTA-CA-170 | Ligand | / | Unkown |
| HY-P11253 | DOTA-Bn-CA-170 | / | Unkown | |
| HY-P11405 | [D-Arg1,D-Trp5,7,9,Leu11]-Substance P | Antagonist | / | Unkown |
| HY-P11700 | AAPDARETA | / | Unkown | |
| HY-P11825 | APH-IN-1 | Inhibitor | / | Unkown |
| HY-P1247A | Calcineurin autoinhibitory peptide TFA | Inhibitor | / | Unkown |
| HY-P1250A | RFRP-3(human) TFA | Agonist | / | Unkown |
| HY-P1345 | TLQP-21 | Agonist | / | Unkown |
| HY-P1366A | des-Gln14-Ghrelin TFA | / | Unkown | |
| HY-P1437A | Neuropeptide S (Mouse) TFA | Agonist | / | Unkown |
| HY-P1479 | Calmodulin-Dependent Protein Kinase II (290-309) | / | Unkown | |
| HY-P2424 | Cholecystokinin-J | / | Unkown | |
| HY-P2722 | Bovine brain Calcineurin | / | Unkown | |
| HY-P3089 | Dendrotoxin K | Inhibitor | / | Unkown |
| HY-P3168 | Martentoxin | Inhibitor | / | Unkown |
| HY-P3187A | exo-β-1,4-xylosidase, Clostridium stercorarium | / | Unkown | |
| HY-P3187B | exo-β-1,4-xylosidase, Bacteroides ovatus | / | Unkown | |
| HY-P3316 | OSK-1 | Inhibitor | / | Unkown |
| HY-P3419A | PAMP-12 (unmodified) TFA | Agonist | / | Unkown |
| HY-P3679 | Neuropeptide Y (1-24) (human) | Activator | / | Unkown |
| HY-P3811 | Autocamtide-3 | / | Unkown | |
| HY-P3943 | Calmodulin Dependent Protein Kinase Substrate Analog | / | Unkown | |
| HY-P3944 | Calmodulin Dependent Protein Kinase Substrate | / | Unkown | |
| HY-P4368 | Z-APF-CMK | Inhibitor | / | Unkown |
| HY-P4397 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin | / | Unkown | |
| HY-P5142 | ω-Hexatoxin-Hv1a | Inhibitor | / | Unkown |
| HY-P5154 | Tamapin | Antagonist | / | Unkown |
| HY-P5319 | MCaE12A | Activator | / | Unkown |
| HY-P5422 | Caloxin 3A1 | Inhibitor | / | Unkown |
| HY-P5869 | Kurtoxin | / | Unkown | |
| HY-P5870 | KTX-Sp2 | Inhibitor | / | Unkown |
| HY-P6008 | Myoregulin | / | Unkown | |
| HY-P6008A | Myoregulin TFA | / | Unkown | |
| HY-P6013 | wt hMLN | Inhibitor | / | Unkown |
| HY-RS01762 | CA1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01763 | CA10 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01764 | CA11 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01765 | CA12 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01766 | CA13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01767 | CA14 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01768 | CA2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01769 | CA3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01770 | CA4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01771 | CA5A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01772 | CA5B Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01773 | CA6 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01774 | CA7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01775 | CA8 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01850 | CALY Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10524 | Pik3ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10525 | Pik3ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10973 | PPP1CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS11023 | PPP3CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00026 | Semotiadil recemate fumarate | / | Unkown | |
| HY-W040028 | Cartap hydrochloride | Inducer | / | Unkown |
| HY-W069974 | Ca2+ -Langerin-IN-1 | / | Unkown | |
| HY-W1049761 | Ti-MUV-10(Ca) | / | Unkown | |
| HY-W127795 | Fluo-3 ammonium | / | Unkown | |
| HY-W250153A | Adenosine 3'-phosphate 5'-phosphosulfate lithium, hydrate | Antagonist | / | Unkown |
| HY-W272201 | Catechol diacetate | Inhibitor | / | Unkown |
| HY-W339833 | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium | / | Unkown | |
| HY-W403046A | D-myo-Inositol-4-phosphate monoammonium | Activator | / | Unkown |
| HY-W414824 | 3β,7β-Dihydroxy-5-cholestenoic acid | / | Unkown | |
| HY-W424792A | O-Desmethyl Brinzolamide hydrochloride | Inhibitor | / | Unkown |
| HY-W565924 | STX107 | / | Unkown | |
| HY-W707161 | 4-Methyl-2-(1-piperidinyl)-quinoline-d10 | / | Unkown | |
| HY-W710915 | Aprindine hydrochloride-d10 | / | Unkown | |
| HY-W711474 | (-)-Menthol-d4 | / | Unkown | |
| HY-W721517 | Gabapentin-d10 | / | Unkown | |
| HY-W751362 | Cetiedil | Inhibitor | / | Unkown |
| HY-W783254 | C18 LPA | / | Unkown | |
| HY-W795960 | D-myo-Inositol 1,4,5-trisphosphate sodium salt | / | Unkown | |
| HY-W838171 | Tiaramide | / | Unkown | |
| HY-Z8176 | (Z)-Flunarizine | Inhibitor | / | Unkown |
| HY-101136 | Dealanylascamycin | Inhibitor | / | Unkown |
| HY-101360R | 1-EBIO (Standard) | Agonist | / | Unkown |
| HY-101669 | TDN345 | Antagonist | / | Unkown |
| HY-101685 | Iganidipine | Antagonist | / | Unkown |
| HY-101727 | Nexopamil racemate | / | Unkown | |
| HY-10341D | Fasudil mesylate | / | Unkown | |
| HY-108163 | SB-237376 free base | Antagonist | / | Unkown |
| HY-108984 | BBMP | / | Unkown | |
| HY-109559 | Pentetate calcium trisodium | / | Unkown | |
| HY-110091 | TRPV1 antagonist 9 | Antagonist | / | Unkown |
| HY-112794 | Topanol CA | 98.11% | Unkown | |
| HY-113037AS | Farnesyl pyrophosphate-d6 | Agonist | / | Unkown |
| HY-113723 | MRS2298 | Antagonist | / | Unkown |
| HY-115231 | ci-IP3/PM | / | Unkown | |
| HY-115767S | (±)-1,2-Diolein-13C3 | Activator | / | Unkown |
| HY-116072 | Antiarrhythmic agent-2 | Inhibitor | / | Unkown |
| HY-116143 | MAGL-IN-12 | Inhibitor | / | Unkown |
| HY-116191 | WJD008 | Inhibitor | / | Unkown |
| HY-116723 | CFMMC | Antagonist | / | Unkown |
| HY-117055 | Ro 18-3981 | Inhibitor | / | Unkown |
| HY-117982 | SKI2496 | / | Unkown | |
| HY-118835S | Zimeldine-d6 | / | Unkown | |
| HY-121186S | Bevantolol-d7 hydrochloride | Antagonist | / | Unkown |
| HY-121253 | NAADP receptor modulator-1 | Inhibitor | / | Unkown |
| HY-121366 | Kadethrin | Inhibitor | / | Unkown |
| HY-121720 | L 657925 | Antagonist | / | Unkown |
| HY-121914 | (2-Chlorophenyl)diphenylmethanol | Inhibitor | 99.92% | Unkown |
| HY-123434 | PD-149164 | Agonist | / | Unkown |
| HY-126072 | (Rac)-GK563 | / | Unkown | |
| HY-126821B | Fluo-3 sodium | / | Unkown | |
| HY-129334 | Macrocalin B | Inhibitor | / | Unkown |
| HY-130358 | PDDHV | Activator | / | Unkown |
| HY-131764 | 2'-O-MB-cGMP sodium | Inhibitor | / | Unkown |
| HY-133614 | Dihydroisopimaric acid | Activator | / | Unkown |
| HY-134368 | Ap3A | Inhibitor | / | Unkown |
| HY-135110A | Rp-8-Br-cGMPS | / | Unkown | |
| HY-135317C | Emavusertib tosylate | / | Unkown | |
| HY-135317D | Emavusertib mesylate | / | Unkown | |
| HY-135317E | Emavusertib maleate | / | Unkown | |
| HY-135317F | Emavusertib phosphate | / | Unkown | |
| HY-135478A | LY393615 free base | Inhibitor | / | Unkown |
| HY-13551C | Amsacrine isethionate | / | Unkown | |
| HY-13551D | Amsacrine lactate | / | Unkown | |
| HY-135556A | Norfluoxetine oxalate | / | Unkown | |
| HY-137162 | Dotarizine | Inhibitor | / | Unkown |
| HY-141613A | Dioleyl phosphatidylserine | Activator | / | Unkown |
| HY-14477 | UPF-1035 | Inhibitor | / | Unkown |
| HY-14656S2 | Diltiazem-d6 hydrochloride | Antagonist | / | Unkown |
| HY-147301B | Resomelagon methanesulfonate | Agonist | / | Unkown |
| HY-149779 | RyR2 stabilizer-1 | Modulator | / | Unkown |
| HY-152051S | Mabuterol-d9 hydrochloride | Agonist | / | Unkown |
| HY-157321 | hCAI/II-IN-7 | Inhibitor | 99.80% | Unkown |
| HY-161848 | TCP-MP-CA | Inhibitor | / | Unkown |
| HY-163660 | Carbonic anhydrase inhibitor 23 | Inhibitor | / | Unkown |
| HY-164090 | Adenosine 3'-phosphate 5'-phosphosulfate | Antagonist | / | Unkown |
| HY-164631 | EL20 | Inhibitor | / | Unkown |
| HY-167203 | AJG049 free base | Antagonist | / | Unkown |
| HY-168377 | Fluo-4 potassium | / | Unkown | |
| HY-168382 | 5R(6S)-EET | Agonist | / | Unkown |
| HY-168382A | 5S(6R)-EET | Agonist | / | Unkown |
| HY-168767 | CA IX-IN-3 | Inhibitor | / | Unkown |
| HY-169206 | PF-3166 | Inhibitor | / | Unkown |
| HY-16935S | Mavatrep-d6 | Antagonist | / | Unkown |
| HY-169780 | (S)-AMG-628 | Antagonist | / | Unkown |
| HY-171187 | Chlorzolamide | Inhibitor | / | Unkown |
| HY-171469 | SKP-451 | Agonist | / | Unkown |
| HY-172321 | Etheno-NAADP sodium | / | Unkown | |
| HY-17404S1 | Cilnidipine-d4 | Inhibitor | / | Unkown |
| HY-174685 | Human FLI1 mRNA | / | Unkown | |
| HY-174829 | 7,4'-Dimethoxy-3-hydroxyflavone | / | Unkown | |
| HY-180864 | CA12 modulator-1 | / | Unkown | |
| HY-183907 | Cicletanine | Inhibitor | / | Unkown |
| HY-19062 | SM-6586 | / | Unkown | |
| HY-50722B | NNC 55-0396 free base | Inhibitor | / | Unkown |
| HY-A0082S | Diphenidol-d10 hydrochloride | Antagonist | / | Unkown |
| HY-B0109AS | Dorzolamide-d3 hydrochloride | Inhibitor | / | Unkown |
| HY-B0109S | Dorzolamide-d5 | Inhibitor | / | Unkown |
| HY-B0493S | Niflumic Acid-d5 | Inhibitor | / | Unkown |
| HY-B0549AS | Flavoxate-d4 hydrochloride | / | Unkown | |
| HY-B0632B | (2R,3R)-Diltiazem hydrochloride | Inhibitor | / | Unkown |
| HY-B0632S2 | Diltiazem-d4 | Inhibitor | / | Unkown |
| HY-B0684S | Iopamidol-d8 | / | Unkown | |
| HY-D0110B | Fura-2 pentasodium | / | Unkown | |
| HY-D1608 | BODIPY FL Thapsigargin | Inhibitor | / | Unkown |
| HY-N0081A | (-)-Praeruptorin A | Inhibitor | / | Unkown |
| HY-N0724R | Mesaconitine (Standard) | Activator | / | Unkown |
| HY-N10754 | Aschantin | Inhibitor | / | Unkown |
| HY-N12164 | Linearmycin B | Inhibitor | / | Unkown |
| HY-N1369S1 | Menthol-d2 | Modulator | / | Unkown |
| HY-N13916 | Alternaric acid | / | Unkown | |
| HY-N14440 | Furaquinocin C | / | Unkown | |
| HY-N5123 | α-L-Rhamnose | / | Unkown | |
| HY-N7063S | Nerol-d2 | / | Unkown | |
| HY-N7063S1 | Nerol-d6 | / | Unkown | |
| HY-N9422 | Adenosine 3'-phosphate 5'-phosphosulfate triethylamine | Antagonist | / | Unkown |
| HY-N9554 | WIN-64821 | Antagonist | / | Unkown |
| HY-P2209 | Nummularine B | Inhibitor | / | Unkown |
| HY-RS19521 | Ppp3ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20700 | Caly Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26016 | Ppp3ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27211 | Caly Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27691 | Ppp2ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W002006 | 6-Amino-1,3-dimethyluracil | / | Unkown | |
| HY-W1113135A | Carboxymethyl-β-cyclodextrin sodium salt, for capillary electrophoresis | / | Unkown | |
| HY-W150752 | Triphenylethylene | 99.86% | Unkown | |
| HY-W166106 | Bromoriluzole | Inhibitor | / | Unkown |
| HY-W250153 | Adenosine 3'-phosphate 5'-phosphosulfate lithium | Antagonist | / | Unkown |
| HY-W288025 | ALXR-agonist-6 | Agonist | / | Unkown |
| HY-W587689 | Juvenile hormone B 3 (mixture of diastereomers) | / | Unkown | |
| HY-W653978 | Cinacalcet-d4 hydrochloride | Agonist | / | Unkown |
| HY-W755295 | Mabuterol hydrochloride | Agonist | / | Unkown |
| HY-W778574 | BAPTA tetracesium | Inhibitor | / | Unkown |
| HY-W931056 | AMG-628 | Inhibitor | / | Unkown |
| HY-U00354 | CP-060 | Antagonist | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99276 | Abagovomab | Inhibitor | 95.00% | Unkown |
| HY-P991649 | Anti-CA6 Antibody (huDS6) | 98.03% | Unkown | |
| HY-P991902 | NAV006 | Inhibitor | / | Unkown |
| HY-P992012 | CA1001 | Agonist | / | Unkown |
| HY-P992349 | DXL625 | / | Unkown | |
| HY-P990830 | Anti-MUC16 Antibody (VK8) | Inhibitor | / | Unkown |